Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Adicet Bio, Inc.
< Previous
1
2
Next >
Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 13, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio to Participate in Upcoming Investor Conferences
August 01, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 31, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
July 08, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 28, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
June 24, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis
June 05, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 31, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference
May 29, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
May 14, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress
May 14, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
May 07, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
April 30, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
April 22, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
April 08, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
March 28, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
March 19, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 11, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
February 29, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 05, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
January 31, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
January 25, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio, Inc. Announces Pricing of Public Offering
January 22, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio, Inc. Announces Proposed Public Offering
January 22, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
January 04, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook
January 03, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
December 29, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting
December 10, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 08, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference
November 07, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.